ALK and anaplastic large cell lymphoma: In particular, two different entities are recognized as systemic forms, the ALK+ and ALK− ALCL [1, 2, 6], on genetic and clinical features, the first one being characterized by the deregulated expression of chimeric proteins expressing the intracytoplasmic domain of the anaplastic lymphoma kinase (ALK) gene.